EPO Enlarged Board to consider principles of claim interpretation

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO Enlarged Board to consider principles of claim interpretation

Sponsored by

inspicos-400px recrop.jpg
advertisement-2098989.jpg

Jakob Pade Frederiksen of Inspicos reviews a recent referral to the EPO Enlarged of Board of Appeal relating to the impact of statements in the description on the interpretation of claims

On April 10 2024, a technical board of appeal of the EPO decided at oral proceedings in relation to case T 439/22 (opposition proceedings against European patent 3 076 804) to refer a fundamental question of law to the Enlarged Board of Appeal (EBA). The issue to be considered by the EBA relates to claim construction, particularly with regard to the significance of statements in the description on the interpretation of claims.

The patent-in-suit relates to a heated aerosol-generating article comprising an aerosol-forming substrate, such as a tobacco substrate. The aim of such aerosol-generating articles is to reduce harmful smoke constituents produced in conventional cigarettes. Claim 1 of the patent recites “a gathered sheet of aerosol-forming material”. According to the description of the patent, the term “gathered” has a broad meaning.

While the written decision of the technical board of appeal has not yet become available at the time of writing, the preliminary opinion of the board, issued on December 5 2023, indicates that a particular piece of prior art potentially deprives the subject matter of claim 1 of novelty if the feature “gathered sheet” is interpreted according to the broad definition indicated in the description. However, the subject matter of claim 1 might be considered novel if the term “gathered sheet” is interpreted more narrowly in accordance with a skilled person’s ordinary understanding of the term.

As noted by the board in the preliminary opinion, according to one line of case law (e.g., T 1473/19), the broad definition given in the description of the patent cannot be left unconsidered, whereas, according to another line of case law (e.g., T 169/20), the description should only be resorted to for interpreting the claims in the exceptional case where clarification is required; i.e., when a skilled person does not have a firm understanding of what a particular feature means in the relevant field of art.

According to the preliminary opinion of the technical board of appeal, a narrow interpretation of the claim language ignoring a definition given in the description would potentially conflict with a broader interpretation by national courts of the Unified Patent Court in infringement proceedings.

more from across site and SHARED ros bottom lb

More from across our site

Niri Shan, the newly appointed head of IP for UK, Ireland and the Middle East, explains why the firm’s international setup has brought UPC success, and addresses German partner departures
Vlad Stanese joins our ‘Five minutes with’ series to discuss potentially precedent-setting trademark and copyright cases and his love for aviation
Heath Hoglund, president of Via LA, discusses how it sets royalty rates and its plans to build on growth in China
Stobbs stands accused of interfering with the administration of justice after Brandsmiths’ client was subjected to an interim injunction for unjustified threats
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
Ed White at Clarivate provides an exclusive insight into the innovation power clusters reshaping Europe and the Middle East’s IP landscape, and why quality is the new currency of invention
In the first in a new podcast series celebrating the tenth anniversary of IP Inclusive, we look back at the network’s origins and discuss its mission
Rebecca Schwarz at Haynes Boone shares how her team secured victory for biopharma client RedHill in a licensing dispute involving a developmental cancer drug
News of a breakaway firm launching in Germany and a spike in vaccine-related patent applications were also among the top talking points
A flurry of hiring activity among UK firms suggests they are confident of mounting a serious challenge at the UPC
Gift this article